Showing results (631-640 of 2,106) with videos related to
Sort By:
Pageof 211
CNS Drugs|February 11, 2022
Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS scoreLuigi Francesco Iannone, Davide Fattori, Silvia Benemei, et al.CNS Drugs|February 15, 2022
Non-parenteral Ketamine for Depression: A Practical Discussion on Addiction Potential and Recommendations for Judicious PrescribingJennifer Swainson, Larry J Klassen, Stefan Brennan, et al.CNS Drugs|January 26, 2022
Restoration of Nusinersen Levels Following Treatment Interruption in People With Spinal Muscular Atrophy: Simulations Based on a Population Pharmacokinetic ModelDrew MacCannell, Zdenek Berger, Janbernd Kirschner, et al.CNS Drugs|January 30, 2022
Lorcaserin for Dravet Syndrome: A Potential Advance Over Fenfluramine?Meir Bialer, Emilio PeruccaCNS Drugs|September 19, 2018
Potential Role of Selective Serotonin Reuptake Inhibitors in Improving Functional Outcome after StrokeJanne Kaergaard Mortensen, Grethe AndersenCNS Drugs|September 22, 2018
Metformin for Weight Gain Associated with Second-Generation Antipsychotics in Children and Adolescents: A Systematic Review and Meta-AnalysisPierre Ellul, Richard Delorme, Samuele CorteseCNS Drugs|September 28, 2018
Palliative Sedation for the Terminally Ill PatientFerdinando Garetto, Ferdinando Cancelli, Romina Rossi, et al.CNS Drugs|March 8, 2022
The Potential of KCNQ Potassium Channel Openers as Novel AntidepressantsSara Costi, Ming-Hu Han, James W MurroughCNS Drugs|February 26, 2022
COMT Inhibitors in the Management of Parkinson's DiseaseMargherita Fabbri, Joaquim J Ferreira, Olivier RascolCNS Drugs|March 2, 2022
Population Pharmacokinetic-B Cell Modeling for Ofatumumab in Patients with Relapsing Multiple SclerosisHuixin Yu, Gordon Graham, Olivier J David, et al.Pageof 211